ãã¡ããç«ã¦ãã°ããã¡ããç«ããã
Â
flickr photo shared by Hey Paul StudiosÂ
èè¬ã§èªç¥çã®å±éºæ§ï¼
Â
Â
 éæµæ§é£éçã®ã¤ããè¸ç¼ãããæã£ã¦ãããèè¬ããããã³ãã³ãé»å®³è¬ï¼PPIï¼ãã ããæ°ããªå¯ä½ç¨ã¨ãã¦èªç¥çã«ãªãå±éºæ§ãé«ã¾ããã¨ãããã¤ãããå ±åãããããã¤ãç¥çµå¤æ§ç¾æ£ã»ã³ã¿ã¼ã®ããªãã¿ã»ãã¼ãã·ã¥æ°ãã¯ãèªç¥çã®ãªã75æ³ä»¥ä¸ã®é«é½¢è
ç´7ä¸äººã対象ã«èª¿æ»ãå®æ½ããã®çµæãPPIãæç¨ãã¦ãã人ã§ã¯ããã§ãªã人ã¨æ¯ã¹ãèªç¥çã«ãªãå±éºæ§ã1.4åé«ãã£ãã¨ã2æ15æ¥çºè¡ã®ç±³å»å¦èªãJAMA Neurologyãï¼é»åçï¼ã«çºè¡¨ããã(Medical Tribuneããå¼ç¨)
Â
èåäºæè
¸æ½°çãéæµæ§é£éçã«å¯¾ãã¦å¦æ¹ãããè¬ãPPIãåååãæããã¨ã¿ã±ããã³ããªã¡ãã©ã¼ã«ãããªã¨ãããããã·ã¦ã 、ã¿ã±ãã£ããªã©ã
Â
ä¸æ¦å¦æ¹ãå§ã¾ãã¨ã漫ç¶ã¨(ãã©ãã©ã¨)å¦æ¹ããããã¨ã®å¤ãè¬ã§ãããã
Â
 ãã¼ãã·ã¥æ°ãã¯ãPPIã®æç¨ãé¿ãããã¨ã§ãèªç¥çãäºé²ã§ããå¯è½æ§ããããã¨ææã
Â
ï½¢PPIãæç¨ããªã=èªç¥çãäºé²ã§ããããï½£ã¨ããããããï½¢PPIå
æãä¸å¿
è¦ã«ç¶ãã¦ããã¨ãèªç¥ççºçã®ãªã¹ã¯ãä¸æããå¯è½æ§ãããï½£ã¨ããè¨ãæ¹ãé©åã ã¨æãã
Â
èé
¸ã¨ãã¿ãã³ãããã¦PPIã¨ã¢ããã¤ãβã®é¢ä¿
Â
èªç¥çäºã
ã¯ãæãããã¿ãã³B12ã®ä»£è¬ã«é¢é£ãã¦ã®ãã¨ããªï¼ã¨æã£ãããã¿ãã³B12ãæ¬ ä¹ããã¨ãæªæ§è²§è¡ãè³èé«é害ãæ«æ¢¢ç¥çµé害ãªã©ãæ¥ãããã
Â
PPIã¯èã®å£ç´°èã«ä½ç¨ãã¦èé
¸ã®åæ³ãæå¶ããè¬ã§ãããÂ
Â
é常åç©æ§ã¿ã³ãã¯è³ªã¨çµåãã¦æåããããã¿ãã³B12ã ããã¾ãèé
¸ã«ãã£ã¦ã¿ã³ãã¯è³ªã¨ã®çµåãå¤ãããããã®å¾ãèã®å£ç´°èããåæ³ãããå
å åã¨çµåãã¦ãæçµçã«ã¯åè
¸ã§å¸åãããã
Â
PPIã§èé
¸ãæå¶ãããã¨éé¢ãã¿ãã³B12ãå°ãªããªãããã®çµæå¸åãããéãæ¸ã£ã¦ãã¾ãã¨ããæ©åºãèããããã
Â
ãã ãã100ä¾ä»¥ä¸ã対象ã¨ããæ¤è¨ã§ã¯å·®ãç¡ãã£ãã¨ããå ±åãããã*1
Â
åèAbstractã§ã¯
Â
 This finding is supported by recent pharmacoepidemiological analyses on primary data and is in line with mouse models in which the use of PPIs increased the levels of β-amyloid in the brains of mice.
Â
ã¨ããè¨è¼ããããPPIãè³ã¸ã®ã¢ããã¤ãβ(ã¢ã«ããã¤ãã¼çºçã®åå ã®ä¸ã¤ã¨è¨ããã¦ããã¿ã³ãã¯)ã®æ²çãå¢ããã®ã§ã¯ï¼ã¨ããèå¯ããªããã¦ããã
Â
JAMA Network | JAMA Neurology | Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis
Â
ãããªèã®é¤èã¯æããã¦ï¼
Â
ã¨ããã§ãããªã³ãã¯ã¿ã¼ã»ãããªææèçã¯ç¾å¨ãä¿éºã§æ²»çãè¡ããããã«ãªã£ããããå¤ãã®æ½è¨ã§å¤å¤ä½µç¨ã«ããé¤èæ²»çãè¡ãããããã«ãªã£ããæè¿ç¥ã£ã¦ã¡ãã£ã¨é©ããã®ã ã、ä½è³çã§ã¯çå
ã®ä¸å¦3å¹´çå
¨å¡ã対象ã«ãããªèã«ææãã¦ãããå¦ãã®æ¤æ»ãè¡ãããã。
Â
ä½è³çå
ãä¸ï¼å
¨å¡ãããªèæ¤æ» å
¨å½åï½ä½è³æ°èLiVE
Â
ã§ã¯ãããªèã¯è¦ã¤ã次第、å¿
ãé¤èããæ¹ãããã®ã ããã?
Â
ããã§ãããã¤ãã®ç 究ããç´¹ä»ã
Â
åäºæè
¸æ½°çæ£è
ã«å¯¾ãã¦é¤èæ²»çãè¡ããæ²»çã®3å¹´å¾ã«æ£è
ã®èã¨é£éãæ¤æ»ããããåæ°ã®æ£è
ã¯é¤èã«æåãã¦ãããåæ°ã¯ãããªèãæ®ã£ã¦ããã
Â
ãããªèãæ®ã£ã¦ãã群ã§ã¯èé£ééæµç(éæµæ§é£éç)ã12.9%ã«ã¿ãããã®ã ããé¤èãæåãã¦ãã群ã§ã¯ããªãã¨26%ã«èé£ééæµçãèªããã¨ã®çµæã*2
Â
ã¤ã¾ãããããªèãé¤èããçµæãèé£ééæµçã®ãªã¹ã¯ãä¸æãã¦ãã¾ã£ãã¨ãããã¨ã
Â
ãããªèã®é¤èã¨ãã¬ããé£éãé£éè
ºçã®çºççã«éç¸é¢é¢ä¿ãè¦ãããã¨ããç ç©¶å ±åãããã®ã§ãèçã®ãªã¹ã¯ã®ã¿ãèãã¦ï½¢ã¨ããããï½£ãããªé¤èããããã¨ã«ã¯æ
éã§ããã¹ãã§ã¯ãªãã ããã?
Â
ã¡ãªã¿ã«ãæ¥æ¬æ¶åå¨ç
å¦ä¼ã®è¦è§£ã§ã¯
Â
 Qï¼èæ½°çãèçããªãã«ãé¢ããããããªèé½æ§ã®å ´åã®é¤èæ²»çã¯ã©ãããã°ããã®ãï¼ Aï¼ãããªèé½æ§ã®å ´åã¯ççç´°è浸潤ãæããæ
¢æ§èçã¨ãªã£ã¦ãã¾ããå
è¦é¡çã«æ½°çããªããã¾ãä¸è¦èçããªãããã«è¦ãã¦ããæ¬å½ã«å
è¦é¡çã«ãããªèæªææã®æ£å¸¸èãå¦ãã確èªãã¦ãã ãããæ£å¸¸èã®å ´åã«ã¯ãRAC(regular arrangement of collecting venules)ãªã©ã®ãããªèæªææã®å
¸åçãªæè¦ãèªããããã¯ãã§ãããã®ãããªæè¦ããªãå ´åã§ãããããªèé½æ§ã§ããã°æ
¢æ§èçãçãã¦ããã¨èããé¤èæ²»çã®é©å¿ã¨ãªãã¾ãã
Â
ã¨ã®ãã¨ã
Â
人éæ¬æ¥ã®èº«ä½ã®ã·ã¹ãã ã«æãå ãããã¨ã®æã
Â
ãããªèã«ããæè¿è©±é¡ã®è
¸å
ç´°èå¢ã«ãããæ°åå¹´ãæ°ä¸å¹´ããããã¯ãã以ä¸ã®æéãããã¦äººéã¨ã®å
±çã·ã¹ãã ãç¯ãã¦ãããæ
ã«ããããã®ä½å
ã§ã®åãã«ã¯ç¸å¿ã®å½¹å²ãããããã«æããï½¢æªçï½£ã®ã¬ããã«ãè²¼ã£ã¦ä¸æ¹çã«é§éããå ´å、ã©ããã«ããå¯ããæ¥ããããªæ°ããã¦ãªããªãã
Â
ï½¢èãçãã£ããã¨ããããPPIï½£ã「風éªãå¼ãããæªæãããããã¨ããããæçå¤ï½£ãªã©ã¯ããããããç¨å¿ãå®æã«ä½¿ããã¨ã¯è«å¤ã ã、ä¸æçã«ä½¿ãå¿
è¦ããã£ãã¨ãã¦ã常ã«æ¢ããã¿ã¤ãã³ã°ã窺ãç¶ããã¹ãã ã¨æãã
Â
èé
¸ã®åæ³ãæãç¶ããã¨ï½¤éæ¬ ä¹ããããããããªã。 - 鹿å
島èªç¥çããã°
ï½¢ãããªèé¤èå¾ã®PPIé·æ使ç¨ã§èçã®ãªã¹ã¯ä¸æï½£ã¨ãããã¥ã¼ã¹ï½¡ - 鹿å
島èªç¥çããã°
Â